Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marc Vasse and Charles Cerf.
Marc Vasse
Connection Strength
0.456
Charles Cerf
  1. A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med. 2021 Jun 25; 59(7):1315-1322.
    View in: PubMed
    Score: 0.233
  2. Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis. J Clin Immunol. 2021 02; 41(2):303-314.
    View in: PubMed
    Score: 0.057
  3. Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19. Am J Infect Control. 2020 12; 48(12):1533-1536.
    View in: PubMed
    Score: 0.057
  4. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful. J Cyst Fibros. 2020 05; 19(3):e16-e17.
    View in: PubMed
    Score: 0.055
  5. COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis. J Hosp Infect. 2020 Jun; 105(2):375-376.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.